Sobi Reports Strong Q4 2024 Results: A Year of Growth and Promising Future Swedish Orphan Biovitrum AB (Sobi) announced its Q4 2024 financial results, showcasing significant revenue increases in key sectors such as haematology.

Sobi Reports Strong Q4 2024 Results: A Year of Growth and Promising Future #Sweden #Stockholm #Sobi #Doptelet #Biovitrum